Skip to main content
. 2022 Sep 1;14(19):1403–1416. doi: 10.4155/fmc-2022-0149

Figure 5. . Chemical structures of protease-targeted chimera molecules as degraders of p300-CBP/CDK2/CDK4/CDK6 for the treatment of cancer (blue indicates the E3 ligase ligand cereblon; red indicates the target inhibitor).

Figure 5. 

PROTAC: Protease-targeted chimera.